|
Published by: Kalorama Information
Published: Nov. 1, 2007 - 276 Pages
Table of Contents
CHAPTER ONE: Executive Summary
- Background
- Scope and Methodology
- Size and Growth of Market
- Analytical Microchips Market
- Analytical Chips for DNA/Gene Microarrays
- Analytical Chips for Protein Microarrays
- Analytical Chips for Microbiology Microarrays
- Analytical Chips for Tissue Microarrays
- Analytical Chips for Cell Microarrays
- Analytical Process Microchips
- Key Occurances in the Analytical Chip Market
CHAPTER TWO: Introduction
- Background
- Early Analytical Chip Products
- New Chip Applications
CHAPTER THREE: DNA/Gene Biochips
- Microbiology Microarrays
- DNA/Gene Microarrays
- DNA/Gene Microarray Production
- Gene and Clone Selection
- DNA/Gene Microarray Applications
- Genotyping
- Gene Expression Measurement
- DNA/Gene Microarray Informatics
- Microbiology Arrays
- Microbiology Array Technology
- Microbiology Microarray Applications
- Drug/Vaccine Discovery and Development
- Microbiology Microarray Commercialization
CHAPTER FOUR: Protein Microarrays
- Background
- Protein Array Applications
- Drug Discovery and Development
- Clinical Diagnostics
- Protein Microarray Commercialization
CHAPTER FIVE: Cell and Tissue Microarray
- Cell Microarray Technology
- Cell Microarray Applications
- Transcriptional Regulation
- Drug Discovery and Development
- Cell Microarray Commercialization
- Tissue Microarrays
- Tissue Microarray Technology
- Tissue Microarray Commercialization
CHAPTER SIX: Process Microchips: Lab-On-A-Chip Technology
- Overview
- Microchip Technology
- LOC Applications
CHAPTER SEVEN: Company Profiles
- Overview
- Accelr8 Technology Corporation
- Affymetrix, Inc.
- Agilent Technologies, Inc.
- Ambion, Inc.
- Bio-Rad Laboratories
- Caliper Life Sciences
- Invitrogen Corporation
- Nanogen, Inc.
- NimbleGen Systems, Inc.
- TeleChem International, Inc.
CHAPTER EIGHT: Market Analysis
- DNA/Gene Microarrays
- Protein Microarrays
- Cell Microarrays
- Tissue Microarrays
- Microbiology Microarrays
CHAPTER NINE: Conclusions and Strategic Implications
- First Conclusion
- Second Conclusion
- Third Conclusion
- Fourth Conclusion
- Fifth Conclusion
- Sixth Conclusion
- Seventh Conclusion
- Eighth Conclusion
- Ninth Conclusion
APPENDIX
table of exhibits
Executive Summary
Figure 1-1: The Market Potential for Analytical Microchips in the United States: 2007 - 2017
Table 1-1 : Estimated Market Potential for United States Market for Analytic Microchips: 2007 - 2017 by Application (DNA/Gene, Protein, Cell, Tissue, Microbiology, Process)
Figure 1-2 : Growth in the United States Market Potential for DNA/Gene Microarray Products: 2007 - 2017
Figure 1-3 : Growth in the United States Market for Protein Microarray Products: 2007 - 2017
Figure 1-4 : Growth in the United States Market for Microbiological Microarray Products: 2007 - 2017
Figure 1-5: Growth in the United States Market for Tissue Microarray Products: 2007 - 2017
Figure 1-6 : Growth in the United States Market for Cell Microarray Products: 2007 - 2017
Figure 1-7 : Growth in the United States Market for Process Microchip Products: 2007 - 2017
ChAPTER THREE: DNA/Gene and Microbiology Microarrays
- Table 3-1:Selected Genomics Databases
CHAPTER FOUR: Protein Microarrays
- Table 4-1: Key Competitors in Antibody and Protein Microarray Technology
- Cell and Tissue Microarray
CHAPTER FIVE: Cell and Tissue Microarray
- Table 5-1: Key Competitors in Cell and Tissue Microarray Technology
- Process Microchips: Lab-On-A-Chip Technology
CHAPTER SIX: Process Microchips: Lab-On-A-Chip Technology
- Table 6-1: Advantages and Disadvantages of LOC Technology
- Table 6-2: Key Competitors in Cell Process Microchip (LOC) Technology
CHAPTER EIGHT: Market Analysis
- Table 8-1: Historic and Projected United States Market Potential for Analytical Microarrays: 2007-2017
- Table 8-2 Historic and Projected United States Market Potential for DNA/Gene Microarrays: 2007-2017
- Figure 8-2 Trends in the Historic and Projected United States Market Potential for DNA/Gene Microarrays: 2007-2017
- Table 8-3 Historic and Projected United States Market Potential for Protein Microarrays: 2007-2017
- Figure 8-3: Trends in the Historic and Projected United States Market Potential for Protein Microarrays: 2007-2017
- Table 8-4: Historic and Projected United States Market Potential for Cell Microarrays: 2007-2017
- Figure 8-4: Trends in the Historic and Projected United States Market Potential for Cell Microarrays: 2007-2017
- Table 8-5: Historic and Projected United States Market Potential for Tissue Microarrays: 2007-2017
- Figure 8-5 Trends in the Historic and Projected United States Market Potential for Tissue Microarrays: 2007-2017
- Table 8-6: Historic and Projected United States Market Potential for Microbiology Microarrays: 2007-2017
- Figure 8-6: Trends in the Historic and Projected United States Market Potential for Microbiology Microarrays: 2007-2017
- Table 8-7: Historic and Projected United States Market Potential for Process Microchips: 2007-2017
- Figure 8-7: Trends in the Historic and Projected United States Market Potential for Process Microchips: 2007-2017 229
AbstractAnalytical microchips can be considered one of the fastest growing technology segments in life sciences. The range of applications to which these miniature laboratories may be directed is very broad — covering fields as different as pharmaceutical development, food testing, clinical diagnostics, forensics, and environmental analysis.
Kalorama's Analytical Chip Technology: U.S. Markets for Lab on a Chip, DNA/Gene, Protein and other Microarrasys) 3rd. Edition looks at the market for analytical microchips with a unique methodology -- the market is expressed in terms of its potential as opposed to experienced and projected revenues. As the author Ken Krul states,
"The status of the current market in terms of revenues is misleading of the potential market as a whole. It does not allow for the understanding of the potential of unmet need. The difference can be as stark as the difference between the surface of the sun and the dark side of the moon."
This is a particular important point in a growing research-based market such as analytical chips. In this report, Krul's unique analysis is based on:
- The current and expected levels of genomic and proteomic research;
- The general trends in technological development for genomics and proteomics, and other factors that affect those trends;
- The trends in pharmaceutical research and development, both in terms of technology and the need for high-throughput approaches and equipment; and
- Costs of analysis based on studies of actual research and projected costs of new technologies by those engaged in their development.
The report breaks up microchip usage into the following segments and forecasts to 2017:
- DNA/Genetics
- Protein
- Cell
- Tissue
- Microbiology
- Process ("Lab on a Chip")
The analysis presented in this report is based on data from a combination of company, government, industrial, institutional and private sources. It includes information from extensive literature reviews, as well as interviews and discussions with experts in the field, including experts in genomics and proteomics, pathologists, research scientists, and business development and marketing managers.
License Note: Kalorama Information's listed default price on its information products reflects a single user license only. Purchasing a departmental license (up to 10 users at one location) or a global site license (entire company) permits multiple individuals in the company to benefit from this resource.
Get Full Details About This Report >>
|
